(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TESERA TRABECULAR TECHNOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TESERA TRABECULAR TECHNOLOGY

ST13

US500000086693997

Class

10

Filing

86693997

Registration

5153651

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

03/08/2026

Trademark type

Word

Nice classes

10

Filing date

07/15/2015

Registration date

03/07/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/14/2024

Last transaction

03/08/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

10/03/2013

First use in commerce

10/03/2013

Drawing code

4

Owner type

03

Owner location

Redlands, CA, US

Examiner

BROOKSHIRE, DAVID AARON

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

KYOCERA MEDICAL TECHNOLOGIES, INC.
KYOCERA INTERNATIONAL, INC.
Renovis Surgical Technologies, Inc.

Representatives

Christopher L. Bernard CLEMENTS BERNARD WALKER

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Orthopedic joint implants made of artificial materials

Publications

History of USPTO decisions and trademark events.

38 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/07/2026

PRA7

REGISTERED - SEC. 7 REQUEST ABANDONED

05/15/2025

PRAM

POST REGISTRATION ACTION MAILED - SEC. 7

10/24/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/23/2024

ES7R

TEAS SECTION 7 REQUEST RECEIVED

04/09/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/14/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/14/2024

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

03/14/2024

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

02/20/2024

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

09/04/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/04/2023

E815

TEAS SECTION 8 & 15 RECEIVED

03/06/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/07/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

03/31/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/17/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

03/07/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/20/2016

PUBO

PUBLISHED FOR OPPOSITION

12/20/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/30/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/16/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/08/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/08/2016

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/03/2016

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/03/2016

GNFR

FINAL REFUSAL E-MAILED

05/03/2016

CNFR

FINAL REFUSAL WRITTEN

05/03/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/29/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/29/2016

ALIE

ASSIGNED TO LIE

04/22/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/06/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/17/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/27/2015

GNRT

NON-FINAL ACTION E-MAILED

10/27/2015

CNRT

NON-FINAL ACTION WRITTEN

10/27/2015

DOCK

ASSIGNED TO EXAMINER

10/26/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/21/2015

NWAP

NEW APPLICATION ENTERED

07/18/2015

Continuous trademark protection

Get notified about every new filing that threatens TESERA TRABECULAR TECHNOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.